FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Accelerate Diagnostics's FCF Yield % or its related term are showing as below:
STU:1A80'
s FCF Yield % Range Over the Past 10 Years
Min: -297.74 Med: -6.46 Max: -0.96
Current: -189.3
During the past 13 years, the highest FCF Yield % of Accelerate Diagnostics was -0.96%. The lowest was -297.74%. And the median was -6.46%.
STU:1A80's FCF Yield % is ranked worse than 95.06% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: -2.675
vs STU:1A80: -189.30
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Accelerate Diagnostics's FCF Yield %
For the Medical Devices subindustry, Accelerate Diagnostics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accelerate Diagnostics's FCF Yield % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Accelerate Diagnostics's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Accelerate Diagnostics's FCF Yield % falls into.
Accelerate Diagnostics FCF Yield % Calculation
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Accelerate Diagnostics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accelerate Diagnostics FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Accelerate Diagnostics FCF Yield % Related Terms
Thank you for viewing the detailed overview of Accelerate Diagnostics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Accelerate Diagnostics (STU:1A80) Business Description
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:1A80 has been successfully added to your 